| Serial Number | 79394512 |
| Word Mark | REVPEM |
| Filing Date | Tuesday, February 6, 2024 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, January 14, 2025 |
| Registration Number | 7646846 |
| Registration Date | Tuesday, January 14, 2025 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 26, 2024 |
| Goods and Services | Anti-infectives; Anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma. |
| Goods and Services | Collection and preservation of human blood; Collection and banking services for tissue and cells, namely, collection and banking of umbilical cord tissue perivascular stem cells; medical diagnostic services; medical treatment services, namely, treatment of cardiovascular, dermatological, ophthalmic, respiratory, gastro-intestinal, autoimmune, metabolic, endocrine, hematological, skeletal, immune, digestive, muscular, genitourinary, transplantation, nephrology, oncology and nervous systems; provision of medical information and data for diagnosis and medical treatment |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 2, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 2, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Novartis AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | CH |
| Party Name | Novartis AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | CH |
| Party Name | Novartis AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | CH |
| Event Date | Event Description |
| Thursday, April 25, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Thursday, May 2, 2024 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Friday, May 10, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, May 10, 2024 | APPLICATION FILING RECEIPT MAILED |
| Monday, May 13, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, May 13, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, May 13, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, May 13, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, May 13, 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Thursday, August 29, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, September 3, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, September 4, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, September 4, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, September 4, 2024 | REFUSAL PROCESSED BY MPU |
| Monday, September 30, 2024 | REFUSAL PROCESSED BY IB |
| Wednesday, October 2, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, October 2, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, October 2, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, October 25, 2024 | FINAL REFUSAL WRITTEN |
| Friday, October 25, 2024 | FINAL REFUSAL E-MAILED |
| Friday, October 25, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Monday, October 28, 2024 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| Monday, October 28, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, October 28, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, October 28, 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Monday, October 28, 2024 | EXPARTE APPEAL RECEIVED AT TTAB |
| Monday, October 28, 2024 | EX PARTE APPEAL-INSTITUTED |
| Tuesday, October 29, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, October 29, 2024 | EXPARTE APPEAL TERMINATED |
| Wednesday, November 20, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 26, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, January 14, 2025 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, January 14, 2025 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, November 26, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 15, 2025 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Thursday, July 31, 2025 | FINAL DISPOSITION PROCESSED |
| Saturday, August 23, 2025 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Wednesday, September 24, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Friday, October 10, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Wednesday, September 24, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Thursday, July 31, 2025 | FINAL DISPOSITION NOTICE SENT TO IB |